ABSTRACT Recently, three inhibitors – ibrutinib, idelalisib, and venetoclax – have been approved for the treatment of chronic lymphocytic...
Supplement 1 - Terapia Evidence Based 2018, Vol. XI, N. 4, December 2018
Riviste e Libri
- Legal Expertise e Medical Information: Open Access e Copyright
- Rising Medical Stars – Medical Writing e Documentazione Scientifica
- Rising Medical Stars – Marketing & Business Development
- Case report e case series – perché pubblicare casi clinici: vantaggi e limiti
- Digital Doctor: contenuti, strumenti e servizi per la brand reputation dell’HCP